Essential thrombocythaemia
RecruitingA study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea
A study to evaluate the effectiveness and safety of iadademstat in adults with essential thrombocythemia who do not respond well to or cannot tolerate hydroxyurea
- Disease:Essential thrombocythaemia
- Substances:Iadademstat
Spain- Participants:18–64 years · 65+ years
- Substances:Iadademstat
- Sponsor:Oryzon Genomics S.A.


